|
Market Closed -
Nasdaq
23:00:00 25/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 116.10 USD | -2.03% |
|
+5.27% | +233.62% |
| Market Cap | 12.55B 11.01B 10.4B 9.48B 17.74B 1,203B 17.87B 124B 48.21B 615B 47.12B 46.1B 1,975B | P/E 2026 * |
56.4x | P/E 2027 * | 27.1x |
|---|---|---|---|---|---|
| Enterprise Value | 12.55B 11.01B 10.4B 9.48B 17.74B 1,203B 17.87B 124B 48.21B 615B 47.12B 46.1B 1,975B | EV / Sales 2026 * |
10.9x | EV / Sales 2027 * | 7.36x |
| Free-Float |
65.88% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CORT | Delayed | |
CBOE
| CORT | Real-time | |
|
London S.E.
| 0I3Q | Delayed | |
|
Tradegate
| HTD | Real-time | |
|
Boerse Muenchen
| HTD | Real-time | |
|
Deutsche Boerse AG
| HTD | Delayed | |
|
Börse Stuttgart
| HTD | Delayed | |
|
Berne S.E.
| HTD | End-of-day quote | |
|
Borsa Italiana
| 1CORT | End-of-day quote |
Last Transcript: Corcept Therapeutics Incorporated
| 1 day | -2.03% | ||
| 1 week | +5.27% | ||
| Current month | +2.43% | ||
| 1 month | -6.05% | ||
| 3 months | +36.99% | ||
| 6 months | +186.88% | ||
| Current year | +233.62% |
| 1 week | 109 |  | 120.44 |
| 1 month | 108.25 | | 121.3 |
| Current year | 28.66 | | 126.38 |
| 1 year | 28.66 | | 126.38 |
| 3 years | 20.84 | | 126.38 |
| 5 years | 15.82 | | 126.38 |
| 10 years | 6.11 | | 126.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Belanoff
CEO | Chief Executive Officer | 68 | 01/01/1999 |
Atabak Mokari
DFI | Director of Finance/CFO | 49 | 01/03/2021 |
Joseph Lyon
CTO | Chief Tech/Sci/R&D Officer | 48 | 01/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Belanoff
BRD | Director/Board Member | 68 | 01/01/1999 |
James Wilson
CHM | Chairman | 82 | 01/01/1999 |
David Mahoney
BRD | Director/Board Member | 71 | 01/07/2004 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/17/26 A | Exercice | Company Secretary | 34,986 | 0.0324% | ||
| 9/16/26 A | Sell | President, Oncology | -296 | 0.0003% | ||
| 9/15/26 A | Sell | Chairman | -10,000 | 0.0093% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.03% | +5.27% | +40.34% | +259.22% | 12.55B | |
| +0.13% | +2.65% | +65.61% | +114.28% | 1,055B | |
| +0.20% | +0.46% | +52.60% | +69.24% | 654B | |
| -0.29% | +0.14% | +20.96% | +70.93% | 467B | |
| -0.85% | +0.98% | +41.29% | +44.38% | 348B | |
| +0.71% | +4.08% | +22.24% | +29.51% | 275B | |
| +1.23% | +0.42% | +14.57% | +12.13% | 258B | |
| +2.11% | +7.51% | +52.89% | +55.37% | 224B | |
| +0.83% | +0.55% | +35.99% | +101.70% | 187B | |
| 0.00% | -10.14% | -29.94% | -60.30% | 171B | |
| Average | +0.12% | +1.19% | +31.66% | +69.65% | 365.09B | |
| Weighted average by Cap. | +0.02% | +1.33% | +41.53% | +68.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.15B 1.01B 950M 866M 1.62B 110B 1.63B 11.37B 4.4B 56.12B 4.3B 4.21B 180B | 1.7B 1.5B 1.41B 1.29B 2.41B 163B 2.43B 16.91B 6.55B 83.48B 6.4B 6.26B 268B |
| Net income | 242M 212M 200M 182M 341M 23.15B 344M 2.4B 928M 11.83B 907M 887M 38.01B | 594M 521M 492M 448M 839M 56.9B 845M 5.89B 2.28B 29.07B 2.23B 2.18B 93.42B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/09/26 | $116.10 | -2.03% | 800,796 |
| 24/09/26 | $118.51 | +4.93% | 983,631 |
| 23/09/26 | $112.94 | -3.88% | 809,873 |
| 22/09/26 | $117.51 | +3.29% | 810,249 |
| 21/09/26 | $113.76 | +3.15% | 1,346,986 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CORT Stock
Select your edition
All financial news and data tailored to specific country editions
